Link Immunotherapeutics Analysis: $51M Raised
What is Link Immunotherapeutics?
Link Immunotherapeutics focuses on developing therapies targeting validated cancer markers and novel combinations. The leadership team has extensive experience in both academic and industry settings, emphasizing a commitment to creating better therapeutics despite the challenges involved.
Location
1616 Eastlake Ave E, Seattle, Washington 98102, United States
Employees
1-10
Founded
2020
Funding Status
Acquired
Product Features & Capabilities
- Therapeutics targeting validated cancer markers
- Novel target combinations for improved efficacy
Use Cases
Develop therapies for specific cancer targets; Collaborate with industry-leading partners for research; Utilize existing knowledge to create better therapeutic molecules
Other Considerations
Founded in 2020; Based in Seattle, Washington; Supported by an experienced Board of Directors
See something that needs updating? Suggest edits to this profile.